The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Safety

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Safety.
Olatoyosi Odenike
Connection Strength
0.041
Safety
  1. An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study. Lancet Haematol. 2019 Apr; 6(4):e194-e203.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.